Haruhiko Kuno

452 citations

16 papers · 357 indexed · h-index 11

Co-authors: Motonobu Satoh Takashi Santou Masao Takeuchi Hideyuki Oki Kenjiro Sato Osamu Uchikawa Masakuni Kori Naoyuki Kanzaki
Topics: Peptidase Inhibition and Analysis (4 papers)Receptor Mechanisms and Signaling (4 papers)Protease and Inhibitor Mechanisms (4 papers)
Cited by: Biological Psychiatry Cancer Research Hematology
Journals: Scientific Reports Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: Japan

In The Last Decade

Haruhiko Kuno

15 papers receiving 355 citations

Peers

Countries citing papers authored by Haruhiko Kuno

Since Specialization

Citations

This map shows the geographic impact of Haruhiko Kuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Kuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Kuno more than expected).

Fields of papers citing papers by Haruhiko Kuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Kuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Kuno. The network helps show where Haruhiko Kuno may publish in the future.

Co-authorship network of co-authors of Haruhiko Kuno

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Kuno. A scholar is included among the top collaborators of Haruhiko Kuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Kuno. Haruhiko Kuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Author Correction: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement 2021 ·Scientific Reports ·Atsushi Suzuki,Akiyoshi Kunugi,(unknown),Noriko Suzuki,Motohisa Suzuki,(unknown),Haruhiko Kuno,Satoshi Sogabe,Yohei Kosugi,(unknown),Tomohiro Kaku,Haruhide Kimura	0
2	Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement 2021 ·Scientific Reports ·Atsushi Suzuki,Akiyoshi Kunugi,(unknown),Noriko Suzuki,Motohisa Suzuki,(unknown),Haruhiko Kuno,Satoshi Sogabe,Yohei Kosugi,(unknown),Tomohiro Kaku,Haruhide Kimura	11
3	Identification of a novel series of potent and selective CCR6 inhibitors as biological probes 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Kyoko Yoshikawa,(unknown),Haruhiko Kuno,(unknown),Kazuyoshi Aso	13
4	HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Akiyoshi Kunugi,(unknown),Haruhiko Kuno,Satoshi Sogabe,Haruhide Kimura	23
5	TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window 2018 ·Neuropsychopharmacology ·Akiyoshi Kunugi,Maiko Tanaka,Atsushi Suzuki,(unknown),Noriko Suzuki,Motohisa Suzuki,Shinji Nakamura,Haruhiko Kuno,(unknown),Satoshi Sogabe,Yohei Kosugi,(unknown),Tomohiro Kaku,Haruhide Kimura	21
6	Identification of 3,4-dihydro-2 H -thiochromene 1,1-dioxide derivatives with a phenoxyethylamine group as highly potent and selective α 1D adrenoceptor antagonists 2017 ·European Journal of Medicinal Chemistry ·(unknown),Hideki Furukawa,Junya Shirai,(unknown),Haruhiko Kuno,(unknown),Masato Yoshida	5
7	Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Oki,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	27
8	Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α_1DAdrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities 2016 ·Journal of Medicinal Chemistry ·(unknown),Yasuhisa Kohara,(unknown),(unknown),Yumi Imai,(unknown),(unknown),(unknown),Hiroshi Nagabukuro,Haruhiko Kuno,Hisashi Fujita,Izumi Kamo,Masato Yoshida	4
9	Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach 2016 ·Journal of Medicinal Chemistry ·Hiroshi Nara,(unknown),Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	42
10	Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site 2014 ·Bioorganic & Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	37
11	Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach 2014 ·Journal of Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	49
12	A simple and rapid reverse transcriptase assay for the detection of retroviruses in cell cultures 1999 ·Cytotechnology ·Haruhiko Kuno,(unknown),Masao Takeuchi,(unknown)	1
13	Establishment of an epidermal growth factor-dependent, multipotent neural precursor cell line 1998 ·In Vitro Cellular & Developmental Biology - Animal ·(unknown),Motonobu Satoh,Haruhiko Kuno,Toshi Iwama,Masao Takeuchi,Akira Hakura,(unknown)	20
14	Platelet‐like particle formation in the human megakaryoblastic leukaemia cell lines, MEG‐01 and MEG‐01s 1998 ·British Journal of Haematology ·(unknown),Motonobu Satoh,Haruhiko Kuno,(unknown),(unknown),Masao Takeuchi	56
15	PLATELET-LIKE PARTICLES RELEASED BY INHIBITION OF DNA SYNTHESIS IN THE HUMAN-MEGAKARYOBLASTIC LEUKEMIA CELL LINE, MEG-01s 1995 ·Masao Takeuchi,Haruhiko Kuno,Motonobu Satoh,(unknown),Michinori Ogura,(unknown)	5
16	Cytokines affecting survival and differentiation of an astrocyte progenitor cell line 1993 ·Developmental Brain Research ·(unknown),Motonobu Satoh,(unknown),Haruhiko Kuno,(unknown)	43

About Haruhiko Kuno

Haruhiko Kuno is a scholar working on Developmental Neuroscience, Cancer Research and Oncology, having authored 16 papers that have together received 357 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Receptor Mechanisms and Signaling (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Biological Psychiatry (18 citations), Cancer Research (104 citations) and Hematology (51 citations). Haruhiko Kuno has collaborated with scholars based in Japan. Frequent co-authors include Motonobu Satoh, Takashi Santou, Masao Takeuchi, Hideyuki Oki, Kenjiro Sato, Osamu Uchikawa, Masakuni Kori, Naoyuki Kanzaki, Hiroshi Nara and Jun Terauchi. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact